UPDATE: Oppenheimer Raises PT on NPS Pharmaceuticals Following Gattex Survey
Oppenheimer Reiterates Outperform Rating on Raptor Pharmaceutical on Positive Developments Supporting Their Thesis
UPDATE: Oppenheimer Raises PT on Celldex Therapeutics on Key Clinical Milestones, Associated Trials Anticipated In 2H13
UPDATE: Oppenheimer Reiterates Overweight on Incyte as Jakafi Profile Continues to Improve